Capital World Investors lifted its stake in shares of HCA Healthcare, Inc. (NYSE:HCA – Free Report) by 0.8% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 4,999,422 shares of the company’s stock after purchasing an additional 40,086 shares during the quarter. Capital World Investors owned 2.19% of HCA Healthcare worth $2,334,040,000 as of its most recent SEC filing.
Other large investors also recently modified their holdings of the company. Palisade Asset Management LLC acquired a new stake in HCA Healthcare in the third quarter valued at about $26,000. Holos Integrated Wealth LLC acquired a new stake in HCA Healthcare in the fourth quarter valued at about $29,000. Ares Financial Consulting LLC acquired a new stake in HCA Healthcare in the fourth quarter valued at about $31,000. JPL Wealth Management LLC acquired a new stake in HCA Healthcare in the third quarter valued at about $33,000. Finally, Aventura Private Wealth LLC acquired a new stake in HCA Healthcare in the fourth quarter valued at about $34,000. 62.73% of the stock is owned by institutional investors and hedge funds.
HCA Healthcare Stock Performance
Shares of HCA stock opened at $372.29 on Friday. The company has a market cap of $82.59 billion, a P/E ratio of 12.80, a PEG ratio of 1.18 and a beta of 1.12. The stock has a 50 day simple moving average of $439.51 and a two-hundred day simple moving average of $477.20. HCA Healthcare, Inc. has a fifty-two week low of $330.00 and a fifty-two week high of $556.52.
HCA Healthcare Dividend Announcement
The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 30th. Shareholders of record on Tuesday, June 16th will be paid a $0.78 dividend. This represents a $3.12 dividend on an annualized basis and a yield of 0.8%. The ex-dividend date of this dividend is Tuesday, June 16th. HCA Healthcare’s dividend payout ratio (DPR) is 10.73%.
HCA Healthcare News Summary
Here are the key news stories impacting HCA Healthcare this week:
- Positive Sentiment: HCA reported first-quarter 2026 revenue of $19.1 billion, highlighting continued top-line growth and reinforcing the company’s scale and demand trends. HCA Healthcare (HCA) Reports Q1 2026 Financial Growth With $19.1B in Revenue
- Positive Sentiment: HCA acquired 17 urgent care clinics in the Carolinas, a move that expands its outpatient network and could support future patient volume and revenue growth. HCA acquires 17 urgent care clinics in the Carolinas
- Positive Sentiment: HCA Healthcare-owned Galen College of Nursing opened a new campus near Space Center Houston, which may help strengthen the company’s nursing pipeline and ease labor constraints over time. HCA Healthcare-owned nursing college opens new campus near Space Center Houston
- Neutral Sentiment: HCA Houston Healthcare Clear Lake is hosting a ribbon cutting for a blood cancer unit, a local service expansion that is positive operationally but likely limited in near-term stock impact. HCA Houston Healthcare Clear Lake to host ribbon cutting for blood cancer unit
- Neutral Sentiment: Additional community and employee-related announcements, including a butterfly release event and leadership updates, are supportive of HCA’s brand but are not likely to move the stock materially. HCA Florida Healthcare hosts a butterfly release to honor cancer patients and their loved ones
- Neutral Sentiment: HCA also hosted emergency response team training, which reflects ongoing operational readiness but is not a major financial catalyst. HCA Healthcare hosts emergency response team training at Tristar Skyline Medical Center
Analyst Ratings Changes
HCA has been the topic of a number of recent research reports. UBS Group lifted their price target on HCA Healthcare from $598.00 to $635.00 and gave the company a “buy” rating in a research note on Monday, February 23rd. Barclays cut their price target on HCA Healthcare from $551.00 to $496.00 and set an “overweight” rating on the stock in a research note on Monday, April 27th. Royal Bank Of Canada cut their price target on HCA Healthcare from $593.00 to $534.00 and set an “outperform” rating on the stock in a research note on Monday, April 27th. Cantor Fitzgerald reissued an “overweight” rating on shares of HCA Healthcare in a research note on Wednesday, March 4th. Finally, TD Cowen lowered their price objective on HCA Healthcare from $561.00 to $500.00 and set a “buy” rating for the company in a research report on Monday, April 27th. Sixteen equities research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $506.14.
View Our Latest Stock Analysis on HCA Healthcare
About HCA Healthcare
HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.
The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.
Read More
- Five stocks we like better than HCA Healthcare
- Samsara Just Answered The AI Question—Is Wall Street Ready To Listen?
- IREN’s 800MW Bet Flips the AI Power Switch
- CrowdStrike Earnings Beat Sparks Selloff—Buy the Dip?
- Tesla’s EV Rebound Leaves Rivian and Lucid Facing a Tougher Investor Test
Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCA – Free Report).
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
